The effect of sex and endurance exercise training on the incretin signaling pathway in 17 rat tissues
Authors:
- Christopher JinCJChristopher Jin
- Gina ManyGMGina Many
- Connor Scott Reynoso SpurrierCSConnor Scott Reynoso Spurrier
- Matthew T. WheelerMWMatthew T. Wheeler
- Joshua N. AdkinsJAJoshua N. Adkins
- Michael P. SnyderMSMichael P. Snyder
- Christopher B. NewgardCNChristopher B. Newgard
- Shlomit Radom-AizikSRShlomit Radom-Aizik
- Dan M. CooperDCDan M. Cooper
- Sue C. BodineSBSue C. Bodine
Open Access
- 1 September 2026
- journal article
- Published by American Physiological Society in Physiological Genomics
- Vol. 58 (9) , 461-472
Abstract
This study provides the first multiomic, multitissue description of incretin signaling receptor expression and regulation in response to endurance exercise training. We identify time point and sex-specific changes in incretin signaling across tissues, highlighting training effects on Gcgr, Gipr, and Sctr regulation in the adrenals, WAT, and brain. These findings help establish an exercise-responsive incretin signaling axis that may identify interactions from incretin-based therapies and exercise-based lifestyle interventions.Keywords
Funding Information
- Common Fund (U24OD026629)
- Common Fund (U24DK112349)
- Common Fund (U24DK112342)
- Common Fund (U24DK112340)
- Common Fund (U24DK112341)
- Common Fund (U24DK112326)
- Common Fund (U24DK112331)
- Common Fund (U24DK112348)
- Common Fund (U01AG055133)
- Common Fund (U01AG055137)
- Common Fund (U01AG055135)
- Common Fund (U01AG070959)
- Common Fund (U01AG070960)
- Common Fund (U01AG070928)
This publication has 75 references indexed in Scilit:
- GLP-1 RAs and Cardiovascular and Kidney Outcomes by Body Mass Index in Type 2 DiabetesJAMA Network Open, 2025
- Interactions between glucagon like peptide 1 (GLP-1) and estrogens regulates lipid metabolismBiochemical Pharmacology, 2024
- Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination TreatmentJAMA Network Open, 2024
- Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trialsAmerican Journal of Preventive Cardiology, 2024
- A comparative transcriptomic analysis of glucagon-like peptide-1 receptor- and glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamusAppetite, 2022
- A novel mouse model of glucagon‐like peptide‐1 receptor expression: A look at the brainJournal of Comparative Neurology, 2020
- Glucagon-like peptide-1 receptor expression and its functions are regulated by androgenBiomedicine & Pharmacotherapy, 2019
- GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trialDiabetologia, 2016
- Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cellsAutonomic Neuroscience, 2004
- Tissue‐specific expression of the human receptor for glucagon‐like peptide‐I: brain, heart and pancreatic forms have the same deduced amino acid sequencesFEBS Letters, 1995